Sirona Biochem Corp.
SRBCF
$0.0418
$0.000.00%
| 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -11.90K | -8.70K | 27.00K | 25.80K | 62.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -11.90K | -8.70K | 27.00K | 25.80K | 62.60K |
| Cost of Revenue | 23.60K | 23.60K | 23.60K | 23.70K | 20.40K |
| Gross Profit | -35.50K | -32.30K | 3.40K | 2.10K | 42.10K |
| SG&A Expenses | 883.30K | 979.90K | 948.20K | 897.30K | 982.10K |
| Depreciation & Amortization | 7.40K | 7.30K | 7.30K | 7.30K | 7.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.66M | 1.51M | 1.79M | 1.74M | 1.61M |
| Operating Income | -1.67M | -1.51M | -1.77M | -1.71M | -1.54M |
| Income Before Tax | -1.96M | -1.71M | -1.97M | -1.89M | -1.69M |
| Income Tax Expenses | 2.10K | 200.00 | -900.00 | -700.00 | -900.00 |
| Earnings from Continuing Operations | -1.96 | -1.71 | -1.97 | -1.88 | -1.69 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.96M | -1.71M | -1.97M | -1.88M | -1.69M |
| EBIT | -1.67M | -1.51M | -1.77M | -1.71M | -1.54M |
| EBITDA | -1.66M | -1.50M | -1.75M | -1.70M | -1.53M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 1.02B | 1.01B | 1.01B | 1.01B | 991.71M |
| Average Diluted Shares Outstanding | 1.02B | 1.01B | 1.01B | 1.01B | 991.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
